PCI Biotech Holding Management
Management criteria checks 4/4
PCI Biotech Holding's CEO is Ronny Skuggedal, appointed in Oct 2013, has a tenure of 9.5 years. total yearly compensation is NOK2.13M, comprised of 78.3% salary and 21.7% bonuses, including company stock and options. directly owns 0.15% of the company’s shares, worth NOK109.89K. The average tenure of the management team and the board of directors is 9.5 years and 6.9 years respectively.
Key information
Ronny Skuggedal
Chief executive officer
NOK 2.1m
Total compensation
| CEO salary percentage | 78.3% |
| CEO tenure | 9.5yrs |
| CEO ownership | 0.1% |
| Management average tenure | 9.5yrs |
| Board average tenure | 6.9yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Dec 31 2022 | n/a | n/a | -NOK 55m |
| Sep 30 2022 | n/a | n/a | -NOK 73m |
| Jun 30 2022 | n/a | n/a | -NOK 84m |
| Mar 31 2022 | n/a | n/a | -NOK 88m |
| Dec 31 2021 | NOK 2m | NOK 2m | -NOK 88m |
| Sep 30 2021 | n/a | n/a | -NOK 90m |
| Jun 30 2021 | n/a | n/a | -NOK 90m |
| Mar 31 2021 | n/a | n/a | -NOK 100m |
| Dec 31 2020 | NOK 3m | NOK 1m | -NOK 72m |
| Sep 30 2020 | n/a | n/a | -NOK 71m |
| Jun 30 2020 | n/a | n/a | -NOK 64m |
| Mar 31 2020 | n/a | n/a | -NOK 61m |
| Dec 31 2019 | NOK 2m | NOK 1m | -NOK 89m |
| Sep 30 2019 | n/a | n/a | -NOK 68m |
| Jun 30 2019 | n/a | n/a | -NOK 62m |
| Mar 31 2019 | n/a | n/a | -NOK 43m |
| Dec 31 2018 | NOK 2m | NOK 1m | -NOK 35m |
| Sep 30 2018 | n/a | n/a | -NOK 46m |
| Jun 30 2018 | n/a | n/a | -NOK 48m |
| Mar 31 2018 | n/a | n/a | -NOK 48m |
| Dec 31 2017 | NOK 1m | NOK 1m | -NOK 43m |
| Sep 30 2017 | n/a | n/a | -NOK 34m |
| Jun 30 2017 | n/a | n/a | -NOK 33m |
| Mar 31 2017 | n/a | n/a | -NOK 35m |
| Dec 31 2016 | NOK 1m | NOK 1m | -NOK 32m |
Compensation vs Market: Ronny's total compensation ($USD199.60K) is below average for companies of similar size in the UK market ($USD348.42K).
Compensation vs Earnings: Ronny's compensation has been consistent with company performance over the past year.
CEO
Ronny Skuggedal (46 yo)
9.5yrs
Tenure
Mr. Ronny Skuggedal has been the Chief Financial Officer at PCI Biotech Holding ASA and PCI Biotech AS since joining in October 2013. He serves as Chief Executive Officer at PCI Biotech Holding ASA since S...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & CFO | 9.5yrs | no data | 0.15% NOK 109.9k | |
| Chief Scientific Officer | 15.3yrs | no data | 0.17% NOK 129.5k | |
| Chief Development Officer | 4.2yrs | no data | 0.068% NOK 50.3k | |
| Acting CDO | no data | NOK 1.46m | no data |
9.5yrs
Average Tenure
61yo
Average Age
Experienced Management: 0JGL's management team is seasoned and experienced (9.5 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Independent Chairman | 7.9yrs | NOK 355.00k | 0.33% NOK 247.1k | |
| Independent Director | 6.9yrs | NOK 220.00k | 0.035% NOK 25.9k | |
| Independent Director | 7.9yrs | NOK 220.00k | 0.027% NOK 20.0k | |
| Independent Director | 4.9yrs | NOK 220.00k | no data | |
| Independent Director | 3.9yrs | NOK 220.00k | no data |
6.9yrs
Average Tenure
64yo
Average Age
Experienced Board: 0JGL's board of directors are considered experienced (6.9 years average tenure).